6 курс / Медицинская реабилитация, ЛФК, Спортивная медицина / Эффекты_трансплантации_мононуклеарных_клеток_пуповинной_крови_человека

111

of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine [Text] / J. Rodda, S. Morgan, Z. Walker // Int Psychogeriatr. – 2009. – V. 21, № 5. –

P. 813-824.

174.Rodrigues, E. M. Enhanced beta-secretase processing alters APP axonal transport and leads to axonal defects [Text] / E. M. Rodrigues, A. M. Weissmiller, L. S. Goldstein // Hum Mol Genet. – 2012. – V. 21, № 21. – P. 4587-4601.

175.Roher, A. E. Atherosclerosis of cerebral arteries in Alzheimer disease [Text] / A. E. Roher, C. Esh, A. Rahman, et al. // Stroke. – 2004. – V. 35, № 11 Suppl 1. – P. 26232627.

176.Rossjohn, J. Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein [Text] / J. Rossjohn, R. Cappai, S. C. Feil, et al. // Nat Struct Biol. – 1999. – V. 6, № 4. – P. 327-331.

177.Russo, C. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain [Text] / C. Russo, S. Salis, V. Dolcini, et al. // Neurobiol Dis. – 2001. – V. 8, № 1. – P. 173-180.

178.Sabo, S. L. The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo [Text] / S. L. Sabo, A. F. Ikin, J. D. Buxbaum, et al. // J Neurosci. – 2003. – V. 23, № 13. – P. 5407-5415.

179.Saido, T. Proteolytic degradation of amyloid beta-protein [Text] / T. Saido, M. A. Leissring // Cold Spring Harb Perspect Med. – 2012. – V. 2, № 6. – P. a006379.

180.Salloway, S. A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease [Text] / S. Salloway, R. Sperling, R. Keren, et al. // Neurology. – 2011. – V. 77, № 13. – P. 1253-1262.

181.Scheff, S. W. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment [Text] / S. W. Scheff, D. A. Price, F. A. Schmitt, et al. // Neurobiol Aging. – 2006. – V. 27, № 10. – P. 1372-1384.

182.Scheff, S. W. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment [Text] / S. W. Scheff, D. A. Price, F. A. Schmitt, et al. // Neurology. – 2007. – V. 68, № 18. – P. 1501-1508.

t.me/medicina_free

112

183.Shankar, G. M. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory [Text] / G. M. Shankar, S. Li, T. H. Mehta, et al. // Nat Med. – 2008. – V. 14, № 8. – P. 837-842.

184.Shankar, G. M. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway [Text] / G. M. Shankar, B. L. Bloodgood, M. Townsend, et al. // J Neurosci. – 2007. – V. 27, № 11. – P. 2866-2875.

185.Shariati, S. A. Redundancy and divergence in the amyloid precursor protein family [Text] / S. A. Shariati, B. De Strooper // FEBS Lett. – 2013. – V. 587, № 13. – P. 20362045.

186.Sheng, M. The postsynaptic organization of synapses [Text] / M. Sheng, E. Kim // Cold Spring Harb Perspect Biol. – 2011. – V. 3, № 12.

187.Sjogren, M. Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment [Text] / M. Sjogren, M. Gisslen, E. Vanmechelen, et al. // Neurosci Lett. – 2001. – V. 314, № 1-2. – P. 33-36.

188.Smith, M. A. Widespread peroxynitrite-mediated damage in Alzheimer's disease [Text] / M. A. Smith, P. L. Richey Harris, L. M. Sayre, et al. // J Neurosci. – 1997. – V. 17, № 8. – P. 2653-2657.

189.Soba, P. Homoand heterodimerization of APP family members promotes intercellular adhesion [Text] / P. Soba, S. Eggert, K. Wagner, et al. // EMBO J. – 2005.

– V. 24, № 20. – P. 3624-3634.

190.Soldano, A. The Drosophila homologue of the amyloid precursor protein is a conserved modulator of Wnt PCP signaling [Text] / A. Soldano, Z. Okray, P. Janovska, et al. // PLoS Biol. – 2013. – V. 11, № 5. – P. e1001562.

191.Sosa, L. J. The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system [Text] / L. J. Sosa, A. Caceres, S. Dupraz, et al. // J Neurochem. – 2017. – V. 143, № 1. – P. 11-29.

192.Sotthibundhu, A. Abeta(1-42) stimulates adult SVZ neurogenesis through the p75 neurotrophin receptor [Text] / A. Sotthibundhu, Q. X. Li, W. Thangnipon, et al. // Neurobiol Aging. – 2009. – V. 30, № 12. – P. 1975-1985.

t.me/medicina_free

113

193.Springer, J. E. Expression of GDNF mRNA in rat and human nervous tissue [Text] / J. E. Springer, X. Mu, L. W. Bergmann, et al. // Experimental Neurology. – 1994. –

V.127, № 2. – P. 167-170.

194.Sun, G. Z. Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene / G. Z. Sun, Y. C. He, X. K. Ma, et al. // CNS Neurosci Ther.

– 2017. – V. 23, № 9. – P. 748-758.

195.Tamayev, R. The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains [Text] / R. Tamayev, D. Zhou, L. D'Adamio // Mol Neurodegener. – 2009. – V. 4. – P. 28.

196.Tanaka, S. Establishment of an Alzheimer's disease model with latent herpesvirus infection using PS2 and Tg2576 double transgenic mice [Text] / S. Tanaka, H. Nagashima // Exp Anim. – 2018. – V. 67, № 2. – P. 185-192.

197.Tang, K. Identification of a novel alternative splicing isoform of human amyloid precursor protein gene, APP639 [Text] / K. Tang, C. Wang, C. Shen, et al. // Eur J Neurosci. – 2003. – V. 18, № 1. – P. 102-108.

198.Tarkowski, E. Intrathecal inflammation precedes development of Alzheimer's disease [Text] / E. Tarkowski, N. Andreasen, A. Tarkowski, et al. // J Neurol Neurosurg Psychiatry. – 2003. – V. 74, № 9. – P. 1200-1205.

199.Terry, R. D. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment [Text] / R. D. Terry, E. Masliah, D.

P.Salmon, et al. // Ann Neurol. – 1991. – V. 30, № 4. – P. 572-580.

200.Terwel, D. Critical role of astroglial apolipoprotein E and liver X receptor-alpha expression for microglial Abeta phagocytosis [Text] / D. Terwel, K. R. Steffensen, P.

B.Verghese, et al. // J Neurosci. – 2011. – V. 31, № 19. – P. 7049-7059.

201.Thal, D. R. Sequence of Abeta-protein deposition in the human medial temporal lobe [Text] / D. R. Thal, U. Rub, C. Schultz, et al. // J Neuropathol Exp Neurol. – 2000. –

V.59, № 8. – P. 733-748.

202.Thaler, J. P. Obesity is associated with hypothalamic injury in rodents and humans [Text] / J. P. Thaler, C. X. Yi, E. A. Schur, et al. // J Clin Invest. – 2012. – V. 122, №

1. – P. 153-162.

t.me/medicina_free

114

203.Theuns, J. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease [Text] / J. Theuns, N. Brouwers, S. Engelborghs, et al. // Am J Hum Genet. – 2006. – V. 78, № 6. – P. 936-946.

204.Torres, L. Toxoplasma gondii alters NMDAR signaling and induces signs of Alzheimer's disease in wild-type, C57BL/6 mice [Text] / L. Torres, S. A. Robinson,

D.G. Kim, et al. // J Neuroinflammation. – 2018. – V. 15, № 1. – P. 57.

205.Tyan, S. H. Amyloid precursor protein (APP) regulates synaptic structure and function [Text] / S. H. Tyan, A. Y. Shih, J. J. Walsh, et al. // Mol Cell Neurosci. – 2012. – V. 51, № 1-2. – P. 43-52.

206.Valiente, M. Neuronal migration mechanisms in development and disease [Text] / M. Valiente, O. Marin // Curr Opin Neurobiol. – 2010. – V. 20, № 1. – P. 68-78.

207.Van de Ven, C. The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration [Text] / C. van de Ven, D. Collins, M.

B.Bradley, et al. // Exp Hematol. – 2007. – V. 35, № 12. – P. 1753-1765.

208.Van der Kant, R. Cellular functions of the amyloid precursor protein from development to dementia [Text] / R. van der Kant, L. S. Goldstein // Dev Cell. – 2015.

– V. 32, № 4. – P. 502-515.

209.Vaz, M. Alzheimer's disease: Recent treatment strategies [Text] / M. Vaz, S. Silvestre // Eur J Pharmacol. – 2020. – V. 887. – P. 173554.

210.Verdier, Y. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease [Text] / Y. Verdier,

M.Zarandi, B. Penke // J Pept Sci. – 2004. – V. 10, № 5. – P. 229-248.

211.Verghese, P. B. Apolipoprotein E in Alzheimer's disease and other neurological disorders [Text] / P. B. Verghese, J. M. Castellano, D. M. Holtzman // Lancet Neurol.

– 2011. – V. 10, № 3. – P. 241-252.

212.Volianskis, A. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1deltaE9-deleted transgenic mice model of β-amyloidosis [Text] / A. Volianskis, R. Kostner, M. Molgaard, et al. // Neurobiol Aging. – 2010. – V. 31, № 7.

– P. 1173-1187.

t.me/medicina_free

115

213.Wada, H. Risk factors of aspiration pneumonia in Alzheimer's disease patients [Text] / H. Wada, K. Nakajoh, T. Satoh-Nakagawa, et al. // Gerontology. – 2001. – V. 47, №

5. – P. 271-276.

214.Wallin, A. K. CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival [Text] / A. K. Wallin, K. Blennow, N. Andreasen, et al. // Dement Geriatr Cogn Disord. – 2006. – V. 21, № 3.

– P. 131-138.

215.Walsh, D. M. Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation [Text] / D. M. Walsh, M. Townsend, M. B. Podlisny, et al. // J Neurosci.

– 2005. – V. 25, № 10. – P. 2455-2462.

216.Wang, Z. Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis [Text] / Z. Wang, B. Wang, L. Yang, et al. // J Neurosci. – 2009. – V. 29, № 35. – P. 10788-10801.

217.Wasco, W. Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor [Text] / W. Wasco, K. Bupp, M. Magendantz, et al. // Proc Natl Acad Sci U S A. – 1992. – V. 89, № 22. – P. 10758-10762.

218.Wei, Z. H. Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer's disease [Text] / Z. H. Wei, Q. B. He, H. Wang, et al. // J Neural Transm (Vienna). – 2007. – V. 114, № 5. – P. 629-634.

219.White, M. R. Alzheimer's associated beta-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes [Text] / M. R. White, R. Kandel, S. Tripathi, et al. // PLoS One. – 2014. – V. 9, № 7. – P. e101364.

220.White, M. R. Critical role of C-terminal residues of the Alzheimer's associated betaamyloid protein in mediating antiviral activity and modulating viral and bacterial interactions with neutrophils [Text] / M. R. White, R. Kandel, I. N. Hsieh, et al. // PLoS One. – 2018. – V. 13, № 3. – P. e0194001.

t.me/medicina_free

116

221.Whitson, J. S. Amyloid beta protein enhances the survival of hippocampal neurons in vitro [Text] / J. S. Whitson, D. J. Selkoe, C. W. Cotman // Science. – 1989. – V. 243,

№4897. – P. 1488-1490.

222.Willem, M. eta-Secretase processing of APP inhibits neuronal activity in the hippocampus [Text] / M. Willem, S. Tahirovic, M. A. Busche, et al. // Nature. – 2015.

– V. 526, № 7573. – P. 443-447.

223.Wollenweber, F. A. Prevalence of cortical superficial siderosis in patients with cognitive impairment [Text] / F. A. Wollenweber, K. Buerger, C. Mueller, et al. // J Neurol. – 2014. – V. 261, № 2. – P. 277-282.

224.World Health Organization: the official web site. – Geneva. – URL: https://www.who.int/en/news-room/fact-sheets/detail/dementia (date of access: 14.05.2021). – Text: electronic.

225.Wozniak, M. A. Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation [Text] / M. A. Wozniak, R. F. Itzhaki, S. J. Shipley, et al. // Neurosci Lett. – 2007. – V. 429, № 2-3. – P. 95-100.

226.Wozniak, M. A. Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques [Text] / M. A. Wozniak, A. P. Mee, R. F. Itzhaki // J Pathol.

– 2009. – V. 217, № 1. – P. 131-138.

227.Wyss-Coray, T. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ [Text] / T. Wyss-Coray, J. D. Loike, T. C. Brionne, et al. // Nat Med. – 2003. – V. 9,

№4. – P. 453-457.

228.Young-Pearse, T. L. A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference [Text] / T. L. Young-Pearse, J. Bai, R. Chang, et al. // J Neurosci. – 2007. – V. 27, № 52. – P. 14459-14469.

229.Zhang, Z. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease [Text] / Z. Zhang, M. Song, X. Liu, et al. // Nat Commun. – 2015. – V. 6. – P. 8762.

230.Zucker, R. S. Short-term synaptic plasticity / R. S. Zucker, W. G. Regehr // Annu Rev Physiol. – 2002. – V. 64. – P. 355-405.

t.me/medicina_free